Regeneron Pharmaceuticals, Inc.
REGN
$901.19
$7.050.79%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.84B | 9.91B | 8.93B | 8.96B | 7.74B |
| Total Receivables | 5.67B | 5.58B | 5.12B | 5.12B | 5.33B |
| Inventory | 2.58B | 2.56B | 2.51B | 2.42B | 2.40B |
| Prepaid Expenses | 386.60M | 574.70M | 360.80M | 406.20M | 411.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 5.50M | -- | -- |
| Total Current Assets | 19.48B | 18.63B | 16.92B | 16.91B | 15.88B |
|
|
|||||
| Total Current Assets | 19.48B | 18.63B | 16.92B | 16.91B | 15.88B |
| Net Property, Plant & Equipment | 4.22B | 4.01B | 3.92B | 3.88B | 3.83B |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.04B | 1.02B | 953.00M | 928.70M | 915.50M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.87B | 2.67B | 2.45B | 2.23B | 1.94B |
| Total Assets | 33.08B | 32.16B | 30.66B | 30.06B | 29.21B |
|
|
|||||
| Total Accounts Payable | 606.60M | 536.60M | 547.30M | 599.50M | 589.20M |
| Total Accrued Expenses | 2.32B | 2.53B | 2.18B | 2.07B | 2.05B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.00M | -- | -- | -- | 12.40M |
| Total Finance Division Other Current Liabilities | 481.50M | 528.80M | 381.10M | 426.30M | 485.30M |
| Total Other Current Liabilities | 481.50M | 528.80M | 381.10M | 426.30M | 485.30M |
| Total Current Liabilities | 3.42B | 3.60B | 3.10B | 3.10B | 3.14B |
|
|
|||||
| Total Current Liabilities | 3.42B | 3.60B | 3.10B | 3.10B | 3.14B |
| Long-Term Debt | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 788.70M | 720.00M | 720.00M | 720.00M | 775.80M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 912.10M | 957.70M | 833.00M | 762.80M | 652.00M |
| Total Liabilities | 7.11B | 7.26B | 6.64B | 6.56B | 6.55B |
|
|
|||||
| Common Stock & APIC | 11.35B | 11.25B | 10.89B | 10.60B | 9.95B |
| Retained Earnings | 27.26B | 26.10B | 25.09B | 24.12B | 23.31B |
| Treasury Stock & Other | -12.64B | -12.45B | -11.96B | -11.23B | -10.59B |
| Total Common Equity | 25.97B | 24.90B | 24.02B | 23.50B | 22.66B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 25.97B | 24.90B | 24.02B | 23.50B | 22.66B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 25.97B | 24.90B | 24.02B | 23.50B | 22.66B |
|
|
|||||
